COMMONWEALTH EQUITY SERVICES, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 312272
WALTHAM, MA
Position in NBIX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,022,999
-$33,677 QoQ
Shares Held
15,356
+5.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $43,907,952 across 35 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
101,839 | $12,038,388 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
300,752 | $6,243,611 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
1,082,680 | $4,493,122 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
146,008 | $4,397,760 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
6,625 | $3,928,492 | |
| 6 | VTRS |
Viatris Inc
|
151,554 | $2,047,494 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
15,356 | $2,022,999 | |
| 8 | HLN |
Haleon plc
|
193,750 | $1,939,437 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,022,999 | 15,356 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,056,676 | 14,501 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,010,662 | 14,323 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,772,354 | 14,101 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,516,436 | 13,711 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,904,994 | 13,956 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,760,100 | 15,276 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,053,485 | 14,916 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,922,742 | 13,941 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,825,798 | 13,857 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,575,787 | 14,007 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,424,307 | 15,104 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,552,512 | 15,338 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,808,082 | 15,138 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,561,074 | 14,698 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,609,102 | 16,507 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,747,968 | 18,645 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,572,493 | 18,463 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,803,587 | 18,805 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,963,917 | 20,180 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,910,281 | 19,643 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,999,814 | 20,864 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,321,494 | 24,142 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,918,850 | 23,925 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,009,691 | 23,220 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||